Clinical trial NCT06708299
Status: RecruitingPhase 3Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
- Record number
- NCT06708299
- Status
- Recruiting
- Type and phase
- Clinical trial, phase 3
- Participants
- Target: 110
- Condition (as registered)
- Recurrent Pericarditis
- Countries
- Canada, Greece, Italy, United States
- Topic in the guide
- Blood Pressure
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: April 7, 2025
- End of data collection for primary results: September 21, 2026
- Trial completion: October 21, 2026
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Blood Pressure: ongoing trials · Thinking of taking part? Which specialist to see